P1.06-12 Defects in Homologous Recombination Repair Indicates Susceptibility for Olaparib Treatment in Malignant Pleural Mesothelioma

Authors :: K.W. Schmid
Thomas Hager
Thomas Herold
Jeremias Wohlschlaeger
Jens Kollmeier
Daniel C. Christoph
Robert Walter
Clemens Aigner
Sabrina Borchert
Michael Wessolly
Fabian Dominik Mairinger
Jan Schmeller
Wilfried Eberhardt
Elena Mairinger
Thomas Mairinger
Till Plönes
Source :: Journal of Thoracic Oncology. 14:S482
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Pulmonary and Respiratory Medicine
chemistry.chemical_compound
Oncology
chemistry
business.industry
Pleural mesothelioma
Cancer research
Medicine
Homologous recombination
business
Olaparib

Full Text Access

Tools